Geneos Wealth Management’s AB InBev BUD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.1K | Hold |
474
| – | – | ﹤0.01% | 1555 |
|
|
2026
Q1 | $32.9K | Hold |
474
| – | – | ﹤0.01% | 1589 |
|
|
2025
Q4 | $30.4K | Hold |
474
| – | – | ﹤0.01% | 1578 |
|
|
2025
Q3 | $28.3K | Sell |
474
-2,652
| -85% | -$167K | ﹤0.01% | 1593 |
|
|
2025
Q2 | $215K | Sell |
3,126
-4,200
| -57% | -$282K | 0.01% | 966 |
|
|
2025
Q1 | $451K | Sell |
7,326
-1,325
| -15% | -$72.5K | 0.02% | 653 |
|
|
2024
Q4 | $433K | Sell |
8,651
-3,374
| -28% | -$195K | 0.02% | 624 |
|
|
2024
Q3 | $797K | Buy |
12,025
+11,596
| +2,703% | +$715K | 0.03% | 448 |
|
|
2024
Q2 | $24.9K | Hold |
429
| – | – | ﹤0.01% | 1278 |
|
|
2024
Q1 | $26.1K | Hold |
429
| – | – | ﹤0.01% | 1276 |
|
|
2023
Q4 | $27.7K | Sell |
429
-936
| -69% | -$55.3K | ﹤0.01% | 1248 |
|
|
2023
Q3 | $75.5K | Buy |
1,365
+648
| +90% | +$36.7K | ﹤0.01% | 958 |
|
|
2023
Q2 | $40.7K | Sell |
717
-14
| -2% | -$847 | ﹤0.01% | 1139 |
|
|
2023
Q1 | $48.8K | Sell |
731
-293
| -29% | -$17.7K | ﹤0.01% | 1092 |
|
|
2022
Q4 | $61.5K | Buy |
1,024
+100
| +11% | +$5.37K | ﹤0.01% | 976 |
|
|
2022
Q3 | $41K | Sell |
924
-939
| -50% | -$48.6K | ﹤0.01% | 1082 |
|
|
2022
Q2 | $102K | Sell |
1,863
-600
| -24% | -$33.7K | 0.01% | 997 |
|
|
2022
Q1 | $147K | Sell |
2,463
-305
| -11% | -$18.8K | 0.01% | 934 |
|
|
2021
Q4 | $167K | Sell |
2,768
-6,368
| -70% | -$370K | 0.01% | 946 |
|
|
2021
Q3 | $516K | Sell |
9,136
-60
| -0.7% | -$3.77K | 0.02% | 557 |
|
|
2021
Q2 | $657K | Sell |
9,196
-1,423
| -13% | -$104K | 0.03% | 486 |
|
|
2021
Q1 | $753K | Buy |
10,619
+429
| +4% | +$27.7K | 0.02% | 517 |
|
|
2020
Q4 | $563K | Sell |
10,190
-1,186
| -10% | -$75K | 0.02% | 508 |
|
|
2020
Q3 | $600K | Buy |
11,376
+225
| +2% | +$12.5K | 0.03% | 392 |
|
|
2020
Q2 | $535K | Buy |
11,151
+4,196
| +60% | +$196K | 0.03% | 396 |
|
|
2020
Q1 | $299K | Buy |
6,955
+3,069
| +79% | +$200K | 0.02% | 498 |
|
|
2019
Q4 | $323K | Buy |
3,886
+223
| +6% | +$18.6K | 0.02% | 541 |
|
|
2019
Q3 | $345K | Sell |
3,663
-449
| -11% | -$42.6K | 0.02% | 495 |
|
|
2019
Q2 | $364K | Sell |
4,112
-714
| -15% | -$61.2K | 0.02% | 501 |
|
|
2019
Q1 | $405K | Buy |
4,826
+864
| +22% | +$66.4K | 0.03% | 457 |
|
|
2018
Q4 | $260K | Buy |
3,962
+528
| +15% | +$40.4K | 0.02% | 522 |
|
|
2018
Q3 | $300K | Sell |
3,434
-307
| -8% | -$29.9K | 0.02% | 509 |
|
|
2018
Q2 | $377K | Sell |
3,741
-103
| -3% | -$10.2K | 0.03% | 383 |
|
|
2018
Q1 | $422K | Buy |
3,844
+184
| +5% | +$20.4K | 0.04% | 340 |
|
|
2017
Q4 | $408K | Sell |
3,660
-68
| -2% | -$8K | 0.04% | 356 |
|
|
2017
Q3 | $444K | Buy |
3,728
+400
| +12% | +$46.8K | 0.04% | 326 |
|
|
2017
Q2 | $367K | Buy |
3,328
+272
| +9% | +$31.1K | 0.04% | 351 |
|
|
2017
Q1 | $335K | Buy |
3,056
+329
| +12% | +$35.4K | 0.03% | 363 |
|
|
2016
Q4 | $287K | Buy |
2,727
+482
| +21% | +$54K | 0.04% | 368 |
|
|
2016
Q3 | $295K | Buy |
2,245
+887
| +65% | +$112K | 0.04% | 363 |
|
|
2016
Q2 | $178K | Buy |
1,358
+324
| +31% | +$40.8K | 0.03% | 467 |
|
|
2016
Q1 | $129K | Buy |
+1,034
| New | +$123K | 0.02% | 522 |
|
Other funds holding BUD
Geneos Wealth Management's BUD Position: Q2 2026 in Review
Geneos Wealth Management held its AB InBev (BUD) position steady in Q2 2026 at 474 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.
Geneos Wealth Management first reported a position in BUD in Q1 2016 and has held it in 42 quarters since. The position peaked at $797K in Q3 2024. 612 funds tracked by Wall St. Rank hold BUD as of Q2 2026.
- Geneos Wealth Management held 474 shares of AB InBev worth $39.1K as of Q2 2026.
- Geneos Wealth Management left its AB InBev share count unchanged in Q2 2026.
- AB InBev made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1555 holding.
- Geneos Wealth Management first reported a position in AB InBev in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's AB InBev position peaked at $797K in Q3 2024.
- 612 funds tracked by Wall St. Rank held AB InBev as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.